PennyMac Mortgage Investment Trust

PennyMac Mortgage Investment Trust

Real Estate

NYSE:PMTU · New York Stock Exchange

Market Cap $893.82M Beta 0.12 P/E (TTM) 6.2
$25.37 -0.04%

-$0.01 today

52W Low $24.95High $26.26

Vol 0.01M · Avg 0.00M

EPS (TTM) $1.64 Div Yield 15.78%REIT - Mortgage

Management

Put operating results in leadership context

Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

6.8%

avg 5.9%

ROIC

506.6%

avg 60.1%

ROA

0.6%

avg 1.1%

Analysis

ROIC is currently the strongest return metric at 506.6% versus its period average of 60.1%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Management

Key executives, compensation & ownership

Management

No executive data available.

Insider Trading

SEC Form 4 transactions — last 12 months

Management

Buys

8

$212,716.61

Sells

0

$0.00

Net Sentiment

+$212,716.61

Net buying

Most Active

Lynch Catherine A.

7 transactions

DateInsiderTypeSharesPriceValue
Jan 23, 2026

Lynch Catherine A.

Direct

Buy684.895$13.28$9,095.41
Jan 23, 2026

Lynch Catherine A.

Direct

Buy766.041$13.20$10,111.74
Nov 17, 2025

SPECTOR DAVID

Direct

Buy10.0K$12.40$124,000.00
Oct 24, 2025

Lynch Catherine A.

Direct

Buy695.841$12.67$8,816.31
Oct 24, 2025

Lynch Catherine A.

Direct

Buy774.009$12.67$9,806.70
Sep 22, 2025

Lynch Catherine A.

Direct

Buy2.8K$12.02$33,932.46
Jul 25, 2025

Lynch Catherine A.

Direct

Buy593.228$12.56$7,450.95
Jul 25, 2025

Lynch Catherine A.

Direct

Buy772.605$12.30$9,503.05

Analysis

Insiders reported 8 buys worth $212,716.61 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $212,716.61. Lynch Catherine A. was the most active insider with 7 transactions.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/A-28.2%
+2.2% (13yr)1 analysts
RevenueN/AN/A-3.8%
+2.8% (13yr)1 analysts
Net IncomeN/AN/A-13.3%
+3.1% (13yr)1 analysts
EBITN/AN/A-12.1%
+4.4% (13yr)1 analysts

Analysis

Recent growth has been strongest in Revenue at -3.8% over three years. Forward estimates point to EBIT at +4.4% (13yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Are PMTU insiders buying or selling?

Recent insider activity shows net selling of $2.45M.

Explore More

Continue the stock analysis

Jump to another research area for this company.